동물용 산소 요법 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Veterinary Oxygen Therapy Market Summary

The global veterinary oxygen therapy market size was estimated at USD 1.29 billion in 2024 and is projected to reach USD 2.47 billion by 2033, growing at a CAGR of 7.63% from 2025 to 2033. The market is experiencing growth driven by the rising prevalence of respiratory and critical conditions in animals, the expansion of veterinary infrastructure and specialized clinics, and advancements in veterinary essential care technologies.

Increasing cases of pneumonia, asthma, cardiac failure, and trauma-induced hypoxemia in companion animals, along with better diagnostic tools, highlight the need for respiratory support. Rising prevalence of respiratory diseases in companion animals and increasing efforts to combat disease outbreaks are expected to fuel market growth rapidly. Veterinarians across the U.S. have reported outbreaks of a canine respiratory illness in August 2023, that do not respond to standard treatments and appears more severe and prolonged than typical canine infectious respiratory disease (CIRD). The exact cause remains unknown. In response, Cornell University's College of Veterinary Medicine, through its Animal Health Diagnostic Center and Riney Canine Health Center, launched a rapid response research project to investigate this disease and develop effective therapeutics for its cure.

In addition, adopting oxygen therapy plays a vital role in stabilizing patients in emergencies and post-surgical care. Clinics and hospitals must invest in oxygen cages, masks, and concentrators. This demand increases veterinary oxygen equipment sales, increases adoption rates, and propels businesses to develop innovative, portable solutions. The market is growing because of the quick advancements in oxygen delivery and monitoring technologies in contemporary veterinary care, such as integrated anesthetic equipment, portable oxygen concentrators, and flow regulators.

Manufacturers are constantly developing small, cost-effective, and easy-to-use products that allow even mobile units and small clinics to offer top-notch care. For instance, in January 2025, Super Air Smart ICU was introduced by Bionet America, Inc., with effective oxygenation, CO2 removal without soda-lime, air purification, and sophisticated climate control that improves the dependability of critical care. These innovations reduce operational complexity and enhance treatment reliability, encouraging veterinarians to adopt oxygen therapy widely. Improved outcomes boost pet owner confidence, leading to greater acceptance of oxygen-based interventions. The availability of diverse, advanced solutions broadens usage across companion, equine, and livestock practices, fueling market expansion.

Furthermore, with the help of government programs and private investments, there is an increasing number of veterinary hospitals, referral centers, and specialist clinics. The services in rural regions are growing with portable oxygen equipment, and the urban cities have emergency rooms and veterinary intensive care units. The expansion of this infrastructure increases the accessibility of oxygen therapy for both livestock farmers and pet owners. Adoption of modern oxygen equipment is fueled by competition among clinics to provide advanced services. In addition, the proliferation of specialist institutions normalizes oxygen therapy as a component of routine veterinary care.

Global Veterinary Oxygen Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary oxygen therapy market report based on product, animal, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Oxygen Concentrator
  • Portable Oxygen Concentrator
  • Stationary Oxygen Concentrator
• Accessories
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Small Animal
• Large Animal
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• ICU
• Homecare setting/postoperative care
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals
• Veterinary Clinics
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Animal
  • 1.2.3. Application
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1 Analysis
  • 1.7.2. Model 2 Analysis
  • 1.7.3. Model 3 Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Prevalence Of Respiratory And Critical Conditions In Animals
    • 3.2.1.2. Expansion Of Veterinary Infrastructure And Specialized Clinics
    • 3.2.1.3. Advancements In Veterinary Critical Care Technologies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Devices
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Analysis
• 3.5. Estimated Animal Population by key country and key species, 2021-2024
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Oxygen Therapy Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Oxygen Therapy Market, By Product Movement Analysis
• 4.3. Veterinary Oxygen Therapy Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Veterinary Oxygen Concentrator
  • 4.4.1. Veterinary Oxygen Concentrator Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Portable Oxygen Concentrator
    • 4.4.2.1. Portable Oxygen Concentrator Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Stationary Oxygen Concentrator
    • 4.4.3.1. Stationary Oxygen Concentrator Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Accessories
  • 4.5.1. Accessories Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Oxygen Therapy Market: Animal Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Oxygen Therapy Market, By Animal Movement Analysis
• 5.3. Veterinary Oxygen Therapy Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 5.4. Small Animal
  • 5.4.1. Small Animal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Large Animal
  • 5.5.1. Large Animal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Oxygen Therapy Market: By Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Oxygen Therapy Market, By Application Movement Analysis
• 6.3. Veterinary Oxygen Therapy Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
  • 6.3.1. ICU
    • 6.3.1.1. ICU Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Homecare setting/postoperative care
    • 6.3.2.1. Homecare setting/postoperative care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Others
    • 6.3.3.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Oxygen Therapy Market: By End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Oxygen Therapy Market, By End Use Movement Analysis
• 7.3. Veterinary Oxygen Therapy Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
  • 7.3.1. Veterinary Hospitals
    • 7.3.1.1. Veterinary Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Veterinary Clinics
    • 7.3.2.1. Veterinary Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Others
    • 7.3.3.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Oxygen Therapy Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2024 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. VETLAND MEDICAL SALES & SERVICES. LLC
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product/Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Airnetic, LLC
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product/Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. CAIRE Inc.
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product/Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Longfian Scitech Co., Ltd.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product/Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. IMEX MEDICAL LIMITED
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product/Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. RWD Life Science Co., Ltd.
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product/Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. AEOLUS International Pet Products, LLC.
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product/Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Koninklijke Philips N.V.
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product/Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Drive DeVilbiss International
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product/Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Shinova Systems
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product/Service Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Strategy Mapping
  • 9.3.12. Mergers & Acquisitions
  • 9.3.13. Partnerships & Collaborations
  • 9.3.14. Product/Service launch
  • 9.3.15. Others
• 9.4. List of other key players